Science Corporation

CompanyUnited States

Science Corporation develops one asset, in phase 3 (PRIMA in geographic atrophy). Mostly device; based in the United States.

1
Asset
Furthest stage
Phase 3
0
Trials
0
Signals

Pipeline

1
  • PRIMA

    Subretinal photovoltaic brain-computer interface implant restoring vision by direct stimulation of retinal neurons.

    Phase 3, Device, geographic atrophy

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Integrity notices10
  • Similar companies6

Intelligence